About ARCEDI
ARCEDI’s mission is to provide pregnant women with a safe, simple and accurate cell-based non-invasive prenatal diagnosis (cbNIPD) by isolating fetal cells from maternal blood for genomic analysis of the fetus
ARCEDI Biotech ApS is a Danish biotech company involved in developing technologies for cell based noninvasive prenatal diagnosis (cbNIPD).
ARCEDI Biotech has proprietary method to enrich fetal cells from circulating maternal blood with high efficiency. Once enriched, the fetal cells can be utilized for downstream analysis using technologies such as FISH, array CGH, Next Generation Sequencing, etc. for the detection of chromosomal and subchromosomal changes in the fetal genome.
THE ARCEDI TEAM
Anne-Marie Bruun
Managing Laboratory Technologist
Anne Katrine Rasmussen
Laboratory Technologist
Anne Schelde Høy
Research Assistant
Brit Andersen
Manager Commercial Activities
Bolette Nicolaisen
Quality Assurance Manager, MSc
Emmeli Mikkelsen
PhD Student
Inga B Christensen
Chief Operating Officer, PhD
Jakob Hedegaard
Sr. Clinical Application Manager, PhD
Katarina Ravn
Laboratory Director, Cand. Polyt
Line Dahl Jeppesen
PhD Student, MSc
Lotte Hatt
Chief Scientific Officer, PhD
Lotte Munkholm Hansen
Laboratory Technologist
Maiken Bruun Kristensen
Laboratory Technologist
Mathias Kølvraa
Chief Information Officer
Mette Overgaard
Laboratory Technologist
Palle Schelde
Chief Executive Officer
Peter Schelde Høy
Research Assistant
Ripudaman Singh
Chief Technology Officer, PhD, MBA
Simone Klavsen
Laboratory Technologist
Gitte Brix
Laboratory Technologist
Maibritt Nørgaard Lauridsen
Laboratory Clinical Geneticist, PhD
Marlene Christina Nielsen
Molecular Biologist, PhD
Maria Bach Laursen
Laboratory Clinical Geneticist, PhD
Mads Tang Dalsgaard
Chief Executive Officer, PhD
Vision
Our vision is to fundamentally transform prenatal diagnostics by making cell-free non-invasive prenatal testing (cfNIPT), chorionic villus sampling (CVS) and amniocentesis (Amnio) obsolete.
Mission
Our mission is to provide pregnant women a safe, simple and accurate cell-based non-invasive prenatal diagnosis (cbNIPD) by isolating and extracting fetal calls from maternal blood for genomic analysis of the fetus.
Partnership
Aarhus University Hospital
The EVITA TEST has been developed in close collaboration with the Department for Ultrasound/Department for Obstetrics and Gynecology and the Department of Clinical Genetics at the Aarhus University Hospital. The scientific collaboration has evolved since 2005 and fundamentally contributed to the achievement of several milestones and results in the research.
Palle Juul-Jensens Boulevard 99
8200 Aarhus N, Denmark
Bagger-Sørensen & Co. A/S
Since 2013 Bagger-Sorensen & Co. A/S has been financial partner in ARCEDI Biotech. Bagger-Sorensen & Co. A/S is the holding and investment company of the Bagger-Sorensen family based in Vejle, Denmark.
Tabletvej 1
7100 Vejle, Denmark
